Journals / Adıyaman Üniversitesi Sağlık Bilimleri Dergisi / 2023 / Cilt: 9 Sayı: 2

The role of immunohistochemical antibodies calretinin, D2-40, p63 and thyroid transcription factor-1 in the differential diagnosis of mesothelioma and lung adenocarcinoma

Mezotelyoma ve akciğer adenokarsinomunun ayırıcı tanısında immünohistokimyasal belirteçlerden calretinin, D2-40, p63 ve tiroid transkripsiyon faktör-1'in rolü

Pages
125–132
Publication Date
2023-08-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We found that calretinin and D2-40 markers for mesothelioma and TTF-1 immunohistochemical markers for lung adenocarcinoma provided a high rate of accurate diagnosis in cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Morphological findings are insufficient in the differential diagnosis of mesothelioma and lung adenocarcinoma.
📊
Key Findings & Data:Materials and Methods: In this study, the pathology archive of lung adenocarcinoma and mesothelioma cases diagnosed in our hospital was examined, and the immunohistochemical markers of calretinin, D2-40, p63 and thyroid transcription factor-1 (TTF-1), which were used for differential diagnosis in these cases, were evaluated.
💡
Conclusion & Impact:Conclusion: We found that calretinin and D2-40 markers for mesothelioma and TTF-1 immunohistochemical markers for lung adenocarcinoma provided a high rate of accurate diagnosis in cases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Akciğer adenokarsinom · Mezotelyoma · D2-40

Abstract

Aim: Morphological findings are insufficient in the differential diagnosis of mesothelioma and lung adenocarcinoma. Immunohistochemical examination is the best auxiliary method. In this study, it was aimed to determine the appropriate antibodies in the differential diagnosis of mesothelioma and lung adenocarcinoma. Materials and Methods: In this study, the pathology archive of lung adenocarcinoma and mesothelioma cases diagnosed in our hospital was examined, and the immunohistochemical markers of calretinin, D2-40, p63 and thyroid transcription factor-1 (TTF-1), which were used for differential diagnosis in these cases, were evaluated. Results: According to the findings obtained, 43 of 45 mesothelioma cases had D2-40 antibody positivity, 44 cases had calretinin antibody positivity, and 45 lung adenocarcinoma cases had antibody positivity. TTF-1 antibody positivity was found in all of them. Conclusion: We found that calretinin and D2-40 markers for mesothelioma and TTF-1 immunohistochemical markers for lung adenocarcinoma provided a high rate of accurate diagnosis in cases.

Özet

Amaç: Mezotelyoma ile akciğer adenokarsinomunun ayırıcı tanısında morfolojik bulgular yetersizdir. İmmünohistokimyasal inceleme en iyi yardımcı yöntemdir. Çalışmada mezotelyoma ile akciğer adenokarsinomunun ayırıcı tanısında uygun belirteçlerin belirlenmesi amaçlanmıştır. Gereç ve Yöntem: Bu çalışmada hastanemizde tanı almış akciğer adenokarsinomu ile mezotelyoma olgularına ait patoloji arşivi incelenerek bu olgularda ayırıcı tanıya giderken kullanılan calretinin, D2-40, p63 ve tiroid transkripsiyon faktör-1 (TTF-1) immünhistokimyasal belirteçleri değerlendirilmiştir. Bulgular: Elde edilen bulgulara göre, 45 mezotelyoma olgusunun 43’ünde D2-40 belirteç pozitifliği, 44’ünde calretinin belirteç pozitifliği, 45 akciğer adenokarsinom olgusunun ise tamamında TTF-1 belirteç pozitifliği bulundu. Sonuç: Mezotelyoma açısından calretinin ve D2-40 belirteçlerinin, akciğer adenokarsinomu açısından ise TTF-1 immünhistokimyasal belirteçlerinin olgularda yüksek oranda doğru tanı sağladığını tespit ettik.

🔖

Cite This Article

ERDOĞAN, M. M., KAVAK, S. Y. (2023). The role of immunohistochemical antibodies calretinin, D2-40, p63 and thyroid transcription factor-1 in the differential diagnosis of mesothelioma and lung adenocarcinoma. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 9 Sayı: 2, 125–132. https://ajindex.com/articles/959247

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Haber SE, Haber JM. Malignant mesothelioma: a clinical study of 238 cases. Industrial health. 2011;49(2):166-72. Kabul S. Primer akciğer adenokarsinomlari ile plevra yerleşimli epiteloid tip malign mezotelyomalarin ayirici tanisinda napsin A, caveolin-1, tip III kollajen ve tenascin-x immünohistokimyasal antikorlarin rolü. [Uzmanlık tezi]. Bursa, Türkiye: Uludag Universitesi; 2015.
  2. Sternberg SS, Mills SE, Carter D. Sternberg's diagnostic surgical pathology. vol 1. Lippincott Williams & Wilkins; 2004. Kaplan S. Determining the position of CEA, HBME-1 and thrombomodülin markers in the differential diagnosis of malign mesothelioma and lung adenocarcinoma. [Uzmanlık tezi]. Elazig, Türkiye: Fırat Universitesi; 2005.
  3. Akyildiz EÜ, Öz B, Aki H, Demirkaya A. Plevral Epiteloid Malign Mezotelyoma ile Adenokarsinom Ayirici Tanisinda Immünhistokimya; Bir Panel Önerisi. Turk Toraks Dergisi. 2010;11(4):144. Aydiner F, Yerci Ö. Differential Diagnosis of Malignant Mesothelioma Versus Primary Pulmonary Adenocarcinoma: An Immunohistoc-Hemical Analysis. Turk Patoloji Derg 2004;20(3-4):60-5.
  4. King J, Hasleton P. Immunohistochemistry and the diagnosis of malignant mesothelioma. Histopathology. 2001;38(5):471-6. Rogers JH. Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons. J Cell Biol. 1987;105(3):1343-53.
  5. Doglioni C, Dei AP, Laurino L, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Path. 1996;20(9):1037-46.
  6. Fetsch PA, Abati A. Immunocytochemistry in effusion cytology: a contemporary review. Cancer. 2001;93(5):293-308.
  7. Leers M, Aarts M, Theunissen P. E-cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma. Histopathology. 1998;32(3):209-16.
  8. Dei Tos AP, Doglionit C. Calretinin: a novel tool for diagnostic immunohistochemistry. Adv Anat Pathol. 1998;5(1):61. Deniz H, Kibar Y, Güldür ME, Bakır K. Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations? Pathol Res Pract. 2009;205(11):749-52.
  9. Bhalla R, Siddiqui MT, Mandich D, et al. Diagnostic utility of D2‐40 and podoplanin in effusion cell blocks. Diagn Cytopathol. 2007;35(6):342-7.
  10. Saad RS, Lindner JL, Lin X, Liu YL, Silverman JF. The diagnostic utility of D2‐40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement. Diagn Cytopathol. 2006;34(12):801-6. Karadeniz C. Küçük